All Insider Transactions
Real-time SEC Form 4 Feed
Who is a Corporate Insider?
Corporate insiders—officers, directors, and 10% owners—possess unique operational insights. By law, they must report their trades via SEC Form 4 filings. While selling often occurs for diversification, voluntary open-market purchases serve as high-conviction signals, reflecting management's true confidence in the company's future value.
Last 7 Days
$299,391,674
Total Buys
$4,857,801,143
Total Sells
Last 30 Days Trend
$2,147,267,635
Total Buys
$11,385,143,371
Total Sells
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 16:16 | 2026-02-18 | AVBH | Avidbank Holdings, Inc. | ROSINUS MIKE | Director | State Commercial Banks | SELL | $30.22 | 11,602 | -$350,612 | 171,520 | -6.3% |
| 2026-02-19 16:00 | 2026-02-17 | ASST | Strive, Inc. | Pham Benjamin | Director, Officer - Chief Financial Officer | Finance Services | BUY | $8.15 | 14,114 | $115,095 | 6,214 | +100.0% |
| 2026-02-19 05:38 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Cumbo Alexander | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $5.82 | 16,644 | -$96,923 | 235,405 | 0.0% |
| 2026-02-19 05:34 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Hanrahan Jessie | Officer - Chief Regulatory Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $5.82 | 4,134 | -$24,074 | 74,318 | 0.0% |
| 2026-02-19 05:32 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Ganot Ilan | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $5.82 | 2,658 | -$15,478 | 27,474 | 0.0% |
| 2026-02-19 05:31 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Herzich Paul | Officer - Chief Technology Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $5.82 | 3,616 | -$21,057 | 72,638 | 0.0% |
| 2026-02-19 05:31 | 2026-02-17 | PATK | PATRICK INDUSTRIES INC | Duthie Joel D | Officer - Chief Legal Officer/Secretary | Motor Vehicle Parts & Accessories | SELL | $141.03 | 2,660 | -$375,140 | 33,018 | -7.5% |
| 2026-02-19 05:31 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Howton David T | Officer - Chief Operating Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $5.82 | 7,469 | -$43,494 | 105,077 | 0.0% |
| 2026-02-19 05:28 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Brooks Gabriel | Officer - Chief Medical Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $0.00 | 0 | $0 | 89,466 | 0.0% |
| 2026-02-19 05:25 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Tan Kevin | Officer - CFO & Treasurer | Biological Products, (No Diagnostic Substances) | OPT+S | $5.82 | 5,404 | -$31,469 | 99,422 | 0.0% |
| 2026-02-19 05:18 | 2026-02-18 | GNK | GENCO SHIPPING & TRADING LTD | Allen Peter George | Officer - Chief Financial Officer | Deep Sea Foreign Transportation of Freight | SELL | $23.27 | 6,232 | -$145,019 | 52,002 | -10.7% |
| 2026-02-19 05:18 | 2026-02-18 | GNK | GENCO SHIPPING & TRADING LTD | WOBENSMITH JOHN C | Director, Officer - Chairman, CEO, and President | Deep Sea Foreign Transportation of Freight | SELL | $23.26 | 18,642 | -$433,613 | 525,375 | -3.4% |
| 2026-02-19 05:18 | 2026-02-18 | GNK | GENCO SHIPPING & TRADING LTD | Christensen Jesper | Officer - Chief Commercial Officer | Deep Sea Foreign Transportation of Freight | SELL | $23.27 | 8,260 | -$192,210 | 78,311 | -9.5% |
| 2026-02-19 05:18 | 2026-02-18 | GNK | GENCO SHIPPING & TRADING LTD | Adamo Joseph | Officer - Chief Accounting Officer | Deep Sea Foreign Transportation of Freight | SELL | $23.27 | 3,227 | -$75,092 | 30,772 | -9.5% |
| 2026-02-19 05:12 | 2026-02-13 | JNJ | JOHNSON & JOHNSON | Swanson James D. | Officer - EVP, CIO | Pharmaceutical Preparations | OPT+S | $243.39 | 62,080 | -$15,109,757 | 25,698 | 0.0% |
| 2026-02-19 05:12 | 2026-02-17 | JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Officer - Exec VP, CFO | Pharmaceutical Preparations | OPT+S | $242.80 | 89,654 | -$21,767,830 | 14,000 | 0.0% |
| 2026-02-19 05:12 | 2026-02-17 | JNJ | JOHNSON & JOHNSON | REED JOHN C | Officer - EVP, Innovative Medicine, R&D | Pharmaceutical Preparations | OPT+S | $243.00 | 53,931 | -$13,105,233 | 10,658 | 0.0% |
| 2026-02-19 05:11 | 2026-02-18 | JNJ | JOHNSON & JOHNSON | Schmid Timothy | Officer - EVP, WW Chair, MedTech | Pharmaceutical Preparations | OPT+S | $244.33 | 22,623 | -$5,527,507 | 26,769 | 0.0% |
| 2026-02-19 05:11 | 2026-02-17 | JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | Officer - EVP, Global Corp Affairs | Pharmaceutical Preparations | OPT+S | $243.39 | 6,197 | -$1,508,288 | 23,003 | 0.0% |
| 2026-02-19 05:05 | 2026-02-17 | BKNG | Booking Holdings Inc. | Fogel Glenn D | Director, Officer - CEO AND PRESIDENT | Transportation Services | SELL | $4,149.75 | 452 | -$1,875,688 | 18,543 | -2.4% |
| 2026-02-19 05:00 | 2026-02-10 | BKNG | Booking Holdings Inc. | Fogel Glenn D | Director, Officer - CEO AND PRESIDENT | Transportation Services | SELL | $4,092.82 | 560 | -$2,291,979 | 18,995 | -2.9% |
| 2026-02-19 04:56 | 2026-02-17 | IVVD | Invivyd, Inc. | Allen Robert D. III | Officer - Chief Scientific Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $1.56 | 37,581 | -$58,600 | 114,487 | 0.0% |
| 2026-02-19 04:51 | 2026-02-17 | IVVD | Invivyd, Inc. | Green Julie | Officer - Chief Human Resources Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $1.56 | 40,627 | -$63,350 | 107,717 | 0.0% |
| 2026-02-19 04:49 | 2026-02-13 | EXEL | EXELIXIS, INC. | Senner Christopher J. | Officer - EVP and CFO | Biological Products, (No Diagnostic Substances) | SELL | $43.32 | 64,895 | -$2,810,998 | 976,092 | -6.2% |
| 2026-02-19 04:49 | 2026-02-17 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Officer - EVP, Commercial | Biological Products, (No Diagnostic Substances) | SELL | $43.52 | 67,814 | -$2,950,940 | 381,908 | -15.1% |
| 2026-02-19 04:49 | 2026-02-13 | EXEL | EXELIXIS, INC. | Eckhardt Sue Gail | Director | Biological Products, (No Diagnostic Substances) | SELL | $43.79 | 3,856 | -$168,854 | 17,524 | -18.0% |
| 2026-02-19 04:49 | 2026-02-17 | IVVD | Invivyd, Inc. | Duke William E. | Officer - Chief Financial Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $1.56 | 40,627 | -$63,350 | 107,717 | 0.0% |
| 2026-02-19 04:48 | 2026-02-13 | EXEL | EXELIXIS, INC. | Oliver Bob | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $43.81 | 30,250 | -$1,325,340 | 21,120 | 0.0% |
| 2026-02-19 04:48 | 2026-02-18 | EXEL | EXELIXIS, INC. | Hefti Brenda | Officer - SVP and General Counsel | Biological Products, (No Diagnostic Substances) | SELL | $44.01 | 18,669 | -$821,623 | 96,512 | -16.2% |
| 2026-02-19 04:47 | 2026-02-17 | IVVD | Invivyd, Inc. | Lee Timothy Edward | Officer - Chief Commercial Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $1.56 | 40,627 | -$63,350 | 117,717 | 0.0% |
| 2026-02-19 04:47 | 2026-02-17 | IVVD | Invivyd, Inc. | Andersen Jill | Officer - Chief Legal Officer, Secretary | Biological Products, (No Diagnostic Substances) | OPT+S | $1.56 | 67,710 | -$105,580 | 181,736 | 0.0% |
| 2026-02-19 04:46 | 2026-02-17 | BETR | Better Home & Finance Holding Co | Smith Chad M. | Officer - Pres & COO, Better Mortgage | Loan Brokers | SELL | $30.07 | 6,000 | -$180,448 | 15,590 | -27.8% |
| 2026-02-19 04:44 | 2026-02-18 | HWM | Howmet Aerospace Inc. | Marchuk Neil Edward | Officer - EVP, CAO | Rolling Drawing & Extruding of Nonferrous Metals | SELL | $251.70 | 45,150 | -$11,364,427 | 107,008 | -29.7% |
| 2026-02-19 04:43 | 2026-02-17 | VIRT | Virtu Financial, Inc. | Cavoli Stephen | Officer - EVP | Security Brokers, Dealers & Flotation Companies | SELL | $38.94 | 28,370 | -$1,104,657 | 116,191 | -19.6% |
| 2026-02-19 04:23 | 2026-02-17 | NRDY | Nerdy Inc. | Pello Jason H. | Officer - Chief Financial Officer | Services-Educational Services | SELL | $0.97 | 49,814 | -$48,320 | 2,646,235 | -1.8% |
| 2026-02-19 04:23 | 2026-02-13 | FAF | First American Financial Corp | KENNEDY PARKER S | Director | Title Insurance | BUY | $67.68 | 59,841 | $4,050,099 | 251,552 | +31.2% |
| 2026-02-19 04:23 | 2026-02-17 | NRDY | Nerdy Inc. | Swenson Christopher C. | Officer - Chief Legal Officer | Services-Educational Services | SELL | $0.97 | 32,641 | -$31,662 | 2,022,742 | -1.6% |
| 2026-02-19 04:17 | 2026-01-21 | LNZA | LanzaTech Global, Inc. | Guardians of New Zealand Superannuation | 10% owner | Industrial Organic Chemicals | BUY | $4.43 | 969,858 | $4,299,962 | 1,302,492 | +291.6% |
| 2026-02-19 04:05 | 2026-02-18 | SYNA | SYNAPTICS Inc | Gupta Vikram | Officer - See Remarks | Semiconductors & Related Devices | SELL | $85.00 | 772 | -$65,620 | 96,768 | -0.8% |
| 2026-02-19 04:00 | 2026-02-13 | CFLT | Confluent, Inc. | Mac Ban Ryan Norris | Officer - Chief Revenue Officer | Services-Prepackaged Software | SELL | $30.58 | 3,768 | -$115,223 | 390,163 | -1.0% |
| 2026-02-19 04:00 | 2026-02-13 | CFLT | Confluent, Inc. | Volpi Michelangelo | Director | Services-Prepackaged Software | SELL | $30.59 | 25,000 | -$764,750 | 155,512 | -13.8% |
| 2026-02-19 04:00 | 2026-02-13 | CFLT | Confluent, Inc. | Narkhede Neha | Director | Services-Prepackaged Software | OPT+S | $30.59 | 80,000 | -$2,447,200 | 28,549 | 0.0% |
| 2026-02-19 04:00 | 2026-02-13 | CFLT | Confluent, Inc. | Vishria Eric | Director | Services-Prepackaged Software | SELL | $30.57 | 61,905 | -$1,892,436 | 663,637 | -8.5% |
| 2026-02-19 04:00 | 2026-02-17 | TKO | TKO Group Holdings, Inc. | Kapral Shane | Officer - Deputy Chief Financial Officer | Services-Amusement & Recreation Services | SELL | $208.01 | 616 | -$128,134 | 1,585 | -28.0% |
| 2026-02-19 03:58 | 2026-02-18 | ABX | Abacus Global Management, Inc. | Ganovsky Matthew | Officer, 10% owner - Co-Founder and President | Investment Advice | SELL | $8.38 | 2,386 | -$20,002 | 8,609,624 | 0.0% |
| 2026-02-19 03:52 | 2026-02-13 | CVEO | Civeo Corp | Engine Capital Management, LP | 10% owner | Hotels, Rooming Houses, Camps & Other Lodging Places | SELL | $28.81 | 426,184 | -$12,277,338 | 77,642 | -84.6% |
| 2026-02-19 03:52 | 2026-02-17 | SIBN | SI-BONE, Inc. | RECUPERO ANTHONY J | Other | Surgical & Medical Instruments & Apparatus | SELL | $15.40 | 21,049 | -$324,203 | 243,418 | -8.0% |
| 2026-02-19 03:51 | 2026-02-17 | WCC | WESCO INTERNATIONAL INC | Lazzaris Diane | Officer - EVP and General Counsel | Wholesale-Electrical Apparatus & Equipment, Wiring Supplies | OPT+S | $304.67 | 20,041 | -$6,105,875 | 28,865 | 0.0% |
| 2026-02-19 03:47 | 2026-02-18 | NMIH | NMI Holdings, Inc. | SHUSTER BRADLEY M | Director, Officer - Executive Chairman | Surety Insurance | OPT+S | $39.63 | 55,000 | -$2,179,623 | 415,411 | 0.0% |
| 2026-02-19 03:47 | 2026-02-18 | ABX | Abacus Global Management, Inc. | Kirby Kevin Scott | Officer, 10% owner - Co-Founder and President | Investment Advice | SELL | $8.38 | 2,386 | -$20,002 | 12,464,670 | 0.0% |
1-50 OF 1,420,580
Understanding SEC Form 4
The SEC Form 4 is a mandatory filing for corporate insiders who trade their company's securities. By analyzing these real-time disclosures, investors can gain critical insights into how those closest to the company perceive its current valuation and future potential.
How to Read the Data
Our conviction heatmap highlights trades that stand out from the noise. While insiders sell for many reasons, they buy with one goal: profit. Focus on large "BUY" transactions relative to an insider's previous holdings to identify high-confidence market moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.